Selective digestive decontamination. Why don't we apply the evidence in the clinical practice?;Descontaminación digestiva selectiva. ¿Por qué no aplicamos la evidencia en la práctica clínica?

Medicina Intensiva

Volumn 31, Issue 3, 2007, Pages 136-145

  Taylor, N ^a   Van Saene, H K F ^a   Abella, A ^b   Silvestri, L ^c   Vucic, M ^d   Peric, Y M ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c Unitá Operativa di Anestesia e Reanimazione Presidio Ospedaliero di Gorizia   (Italy)

^d SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Infection; Mortality; Selective digestive decontamination

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFOTAXIME; COLISTIN; NYSTATIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIGESTION; HUMAN; INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; PNEUMONIA; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELECTIVE DIGESTIVE DECONTAMINATION; SYSTEMATIC REVIEW;

EID: 34249942908     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74792-7     Document Type: Article

References (107)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med. 2001;29: 1303-10.
2. van Saene HKF, Petros AJ, Ramsay G, Baxby D. All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med. 2003;29:677-90.
3. Silvestri L, Kerr S, Gullo A. Prevention of infection using selective decontamination of the digestive tract. En: van Saene HKF, Silvestri L, de la Cal MA, editors. Infection control in the intensive care unit. 2nd ed. Milano: Springer-Italia; 2005. p. 297-312.
4. Sanchez M, Mir N, Canton R, et al. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients. A double-blind, randomized, placebo-controlled study [abstract J-119]. 37th ICAAC, Toronto, Canada; 1997. p. 310.
5. Silvestri L, van Saene HK, Milanese M, Fontana F, Gregori D, Oblach L, et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomized trial. Eur Respir J. 2004; 23:921-6.
6. Abele-Horn M, Dauber A, Bauernfeind A, Russwurm W, Seyfarth-Metzger I, Gleich P, et al. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med. 1997;23:187-95.
7. Aerdts SJ, van Dalen R, Clasener HA, Festen J, van Lier HJ, Vollaard EJ. Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen. Chest. 1991;100: 783-91.
8. Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis. 1996;22:997-1003.
9. Barret JP, Jeschke MG, Herndon DN. Selective decontamination of the digestive tract in severely burned pediatric patients. Burns. 2001;27:439-45.
10. Bergmans DC, Bonten MJ, Gaillard CA, Paling JC, van der Geest S, van Tiel FH, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001;164:382-8.
11. Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, et al. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med. 1994;22:40-9.
12. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P. Smilie J. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery. 1991;110:303-9.
13. Boland JP, Sadler DL, Stewart W, Wood DJ, Zerick W, Snodgras KR. Reduction of nosocomial respiratory infections in multiple trauma patients requiring mechanical ventilation by selective parenteral and enteral antisepsis regimen (SPEAR) in the intensive care [abstract no 0465]. Seventeenth international congress of chemotherapy Berlin; 1991.
14. Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, et al. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med. 2002;30:38-43.
15. Brun-Buisson C, Legrand P, Rauss A, Montravers F, Besbes M, Meakins JL, et al. Intestinal decontamination for control of nosocomial multi-resistant gram-negative bacilli. Ann Intern Med. 1989;110:873-81.
16. de la Cal, Cerda E, García-Hierro P, van Saene HKF, Gómez-Santos D, Negro E, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo controlled, double blind trial. Ann Surg. 2005;241:424-30.
17. Cerra FB, Maddaus MA, Dunn DL, Wells CL, Konstantinides NN, Lehman SL, et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg. 1992;127:163-9.
18. Cockerill FR, III, Muller SR, Anhalt JP, Marsh HM, Farnell MB, Mucha P, et al. Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med. 1992;117:545-53.
19. Ferrer M, Torres A, González J, de la Bellacasa JP, ElEbiary M, Roca M. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med. 1994;120: 389-95.
20. Finch RG, Tomlinson P, Holliday M, Sole K, Stack C, Rocker G. Selective decontamination of the digestive tract (SDD) in the prevention of secondary sepsis in a medical/surgical intensive care unit [abstract no 0471]. Seventeenth international congress of chemotherapy Berlin; 1991.
21. Flaherty J, Nathan C, Kabins SA, Weinstein RA. Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis. 1990;162:1393-7.
22. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N Engl J Med. 1992;326:594-9.
23. Gaussorgues P, Salord F, Sirodot M, Tigaud S, Cagnin S, Gerard M, et al. Efficacité de la décontamination digestive sur la survenue des bactériémies nosocomiales chez les patients sous ventilation méchanique et recevant des betamimétiques. Réanimation Soins Intensifs Médecin d'Urgence. 1991;7:169-74.
24. Georges B, Mazerolles M, Decun JF, Rouge P, Pomies S, Cougot P, et al. Décontamination digestive sélective résultats d'une étude chez polytraumatisés. Réanimation Urgence. 1994;3:621-7.
25. Hammond JM, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet. 1992;340:5-9.
26. Hellinger WC, Yao JD, Álvarez S, Blair JE, Cawley JJ, Paya CV, et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation. 2002;73:1904-9.
27. Jacobs S, Foweraker JE, Roberts SE. Effectiveness of selective decontamination of the digestive tract (SDD) in an ICU with a policy encouraging a low gastric pH. Clin Intensive Care. 1992;3:52-8.
28. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PPM, Vroom MB, Dankert J, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362: 1011-6.
29. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, Hulstaert PF, Vos A, Verhoef J, et al. Prevention of colonization and infection in critically ill patients: a prospective randomized study. Crit Care Med. 1988;16:1087-93.
30. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med. 1993;21:1466-73.
31. Krueger WA, Lenhart FP, Neeser G, Ruckdeschel G, Schreckhase H, Eissner HJ, et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 2002; 166:1029-37.
32. Laggner AN, Tryba M, Georgopoulos A, Lenz K, Grimm G, Graninger W, et al. Oropharyngeal decontamination with gentamicin for long-term ventilated patients on stress ulcer prophylaxis with sucralfate? Wien Klin Wochenschr. 1994;106:15-9.
33. Lingnau W, Berger J, Javorsky F, Lejeune P, Mutz N, Benzer H. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma. 1997;42:687-94.
34. Luiten EJT, Hop WCJ, Lange JF, Braining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57-65.
35. Martínez-Pellus AE, Merino P, Bru M, Conejero R, Seller G, Muñoz C, et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med. 1993;21:1684-91.
36. Martínez-Pellus AE, Merino P, Bru M, Canovas J, Seller G, Sapina J, et al. Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination. Intensive Care Med. 1997;23:1251:7.
37. Palomar M, Álvarez-Lerma F, Jorda R, Bermejo B, for the Catalan study group of nosocomial pneumonia prevention. Prevention of nosocomial pneumonia in mechanically ventilated patients: selective decontamination versus sucralfate. Clin Intensive Care. 1997;8:228-35.
38. Pneumatikos I, Koulouras V, Nathanail C, Goe D, Nakos G. Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma. Intensive Care Med. 2002;28:432-7.
39. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA. 1991;265:2704-10.
40. Quinio B, Albanese J, Bues-Charbit M, Viviand X, Martin C. Selective decontamination of the digestive tract in multiple trauma patients. A prospective, double-blind, randomized, placebo-controlled study. Chest. 1996;109:765-72.
41. Rayes N, Seehofer D, Hansen S, Bouesein K, Muller AR, Serke S, et al. Early enteral supply of Lactobacillus and fibre versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation. 2002;74:123-8.
42. Rocha LA, Martín MJ, Pita S, Paz J, Seco C, Margusino L, et al. Prevention of nosocomial infections in critically ill patients by selective decontamination of the digestive tract. A randomised, double blind, placebo controlled study. Intensive Care Med. 1992;18:398-404.
43. Rodríguez-Roldán JM, Altuna-Cuesta A, López A, Carrillo A, García J, León J, et al. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med. 1990;18:1239-42.
44. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology. 1993;17:196-201.
45. Rolando N, Wade JJ, Stangou A, Gimson AE, Wendon J, Philpott-Howard J, et al. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg. 1996;2:8-13.
46. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, et al. Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Eur J Epidemiol. 1998;14:719-27.
47. Sánchez GM, Cambronero Galache JA, López DJ, Cerda CE, Rubio BJ, Gómez Aguinaga MA, et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med. 1998; 158:908-16.
48. Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg. 1997;225:172-80.
49. Smith SD, Jackson RJ, Hannakan CJ, Wadowsky RM, Tzakis AG, Rowe MI. Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation. 1993;55:1306-9.
50. Stoutenbeek CP, van Saene HKF, Zandstra DF. Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. En: Faist EBAE, Schildberg FW, editors. Immune consequences of trauma, shock and sepsis. Lengerich: Pabst Science Publishers; 1996. p. 1055-66.
51. Stoutenbeek CP, van Saene HKF, Little RA, Whitehead A. The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients. Intensive Care Med. 2007; 33:261-70.
52. Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection. Lancet. 1990;335:704-7.
53. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder VA. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective, randomized study. Intensive Care Med. 1989;15:424-31.
54. Unertl K, Ruckdeschel G, Selbmann HK, Jensen U, Forst H, Lenhart FP, et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med. 1987;13:106-13.
55. Verwaest C, Verhaegen J, Ferdinande P, Schets M, Berghe vd G, Verbist L. Randomized controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multi-disciplinary intensive care unit. Crit Care Med. 1997;25: 63-71.
56. Wiener J, Itokazu G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind, placebo controlled trial of selective digestive decontamination in a medical, surgical intensive care unit. Clin Infect Dis. 1995;20:861-7.
57. Winter R, Humphreys H, Pick A, MacGowan AP, Willatts SM, Speller DC. A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother. 1992;30:73-87.
58. Zobel G, Kuttnig M, Grubbauer HM, Semmelrock HJ, Thiel W. Reduction of colonization and infection rate during pediatric intensive care by selective decontamination of the digestive tract. Crit Care Med. 1991;19:1242-6.
59. Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Crit Care Med. 2002;30:1204-9.
60. Selective Decontamination of the Digestive Tract Trialists Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Br Med J. 1993;307:525-32.
61. Heyland DK, Cook DJ, Jaescher R, Griffith L, Lee HN, Guyatt GH. Selective decontamination of the digestive tract. An overview. Chest. 1994;105:1221-9.
62. Kollef M. The role of selective digestive tract decontamination on mortality and respiratory tract infections. Chest. 1994; 105:1101-8.
63. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. Br Med J. 1998;316:1275-85.
64. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients. A systematic review of the evidence. Arch Surg. 1999;134:170-6.
65. Redman R, Ludington E, Crocker M, Wittes J, Bellm J, Carlet J and the VAP advisory group. Analysis of respiratory and non-respiratory infections in published trials of selective decontamination [abstract no 586]. Intensive Care Med. 2001;27 Suppl: S285.
66. Liberati A, D'Amico R, Pifferi S, Leonetti C, Torri V, Brazzi L, et al. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care [Cochrane Review]. En: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons Ltd; 2004.
67. Safdar N, Said A, Lucey MR. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: A systematic review and meta-analysis. Liver Transplantation. 2004;10:817-27.
68. Silvestri L, van Saene HKF, Milanese M, Gregori D. Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med. 2005;31:898-901.
69. Sánchez M, Mir N, Canton R, et al. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients. A double-blind, randomized, placebo-controlled study [abstract J-119], 37th ICAAC, Toronto, Canada; 1997. p. 310.
70. Silvestri L, van Saene HKF, Milanese M, Fontana F, Gregori D, Oblach L, et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomized trial. Eur Respir J. 2004;23:921-6.
71. Stiefel U, Paterson DL, Pultz NJ, Gordon SM, Aron DC, Donskey CJ, et al. Effect of increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol. 2004;25:380-3.
72. Salgado CD, Giannetta ET, Farr BM. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol. 2004;25:413-7.
73. Hammond JMJ, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med. 1995;23:637-45.
74. Stoutenbeek CP, van Saene HKF, Zandstra DF. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother. 1987;19:513-20.
75. Lingnau W, Berger J, Javorsky F, Fille M, Allerberger F, Benzor H. Changing bacterial ecology during a five year period of selective intestinal decontamination. J Hosp Infect. 1998;39: 195-206.
76. Leone M, Albanese J, Antonini F, Nguejen-Michel A, Martin C. Long-term [6-year] effect of selective decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med. 2003;31:2090-5.
77. Tetteroo GWM, Wagenvoort JHT, Bruining HA. Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother. 1994;34:139-48.
78. de la Cal MA, Cerda E, van Saene HKF, García-Hierro P, Negro E, Parra ML, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect. 2004;56:175-83.
79. Sarginson RE, Taylor N, Reilly N, Baines PB, Van Saene HK. Infection in prolonged pediatric critical illness: A prospective four-year study based on knowledge of the carrier state. Crit Care Med. 2004;32:839-47.
80. Abella A, de la Cal MA, Cerda E, López L, Alia I, García-Hierro P, et al. Control of MRSA endemicity with enteral vancomycin in a burn intensive care unit [abstract 556]. Intensive Care Med. 2004;30 Suppl 1:S145.
81. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000:342;1301-8.
82. Bernard GR, Vincent J-L, Laterre PF, López-Rodríguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:799-09.
83. van den Berghe G, Wouters P, Weekers F, Verwaest C, Brayninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;245:1359-67.
84. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fluorocortisone on mortality in patient with septic shock. JAMA. 2002;288:862-71.
85. Nixon JR, Nielsen MS. Selective decontamination of the digestive tract - current national practice. Br J Anaesth. 2000;84: 682P-3P.
86. Bogaards MJ. An inventarisation of the products. Selective digestive decontamination in the Netherlands. Pharm Weekbl. 2001;136:706-12.
87. Aarts MA, Marshall JC. In defense of evidence. The continuing saga of selective decontamination of the digestive tract. Am J Respir Crit Care Med. 2002;166:1014-5.
88. Vincent JL. Selective digestive decontamination for everyone, everywhere? Lancet. 2003;362:1006-7.
89. Farr BM. Reasons for non-compliance with infection control guidelines. Infect Control Hosp Epidemiol. 2000;21:411-6.
90. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendation of clinical experts. JAMA. 1992;268:240-8.
91. Vincent JL. Evidence-based medicine in the ICU. Important advances and limitations. Chest. 2004;126:592-600.
92. Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med. 2004;32:1396-405.
93. Kollef MH. Selective digestive decontamination should not be routinely employed. Chest. 2003;123:464S-8S.
94. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM. Guideline for the prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol. 1994;15: 587-625.
95. Fabregas N, Alcon A, Torres A. Lower airway infection. En: van Saene HKF, Silvestri L, de la Cal MA, editors. Infection control in the intensive care unit. 2nd ed. Milano, Springer-Italia; 2005. p. 315-55.
96. Collard HR, Saint S, Matthay MA. Prevention of ventilator-asociated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
97. Dodek P, Keenan S, Cook D, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004;141:305-13.
98. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia. Comments and responses. Ann Intern Med. 2004;140:486-7.
99. Ebner W, Kropec-Hubner A, Daschner FD. Bacterial resistance and overgrowth due to selective decontamination of the digestive tract. Eur J Clin Microbiol Infect Dis. 2000;19:243-7.
100. Baines P, van Saene H. Selective decontamination of the digestive tract and prevention of ventilator-associated pneumonia. Ann Intern Med. 2004;141:577-8.
101. van Saene HKF, de la Cal MA, Silvestri L, Baines P. The Emperor's new clothes. Ann Intern Med Epub; 2004.
102. European Society of Intensive Care Medicine, Société Réanimation de Langue Française. The first European Consensus Conference in Intensive Care Medicine: selective decontamination of the digestive tract in intensive care patients. Infect Control Hosp Epidemiol. 1992;13:609-11.
103. Bonten MJ, van Tiel FH, van der Geest S, Smeets HG, Stobberingh EE, Gaillard CA. Enterococcus faecalis pneumonia complicating topical antimicrobial prophylaxis. N Engl J Med. 1993;328:209-10.
104. Viviani M, Silvestri L, van Saene HKF, Gullo A. Surviving sepsis campaign guidelines: selective decontamination of the digestive tract still neglected. Crit Care Med. 2005;33:361-72.
105. Torres A, Carlet J, European Task Force on Ventilator-Associated Pneumonia. Ventilator-associated pneumonia. Eur Respir J. 2001;17:1034-45.
106. Royal College of Pathologists. Continuing professional development. J Hosp Infect. 2002;50:161.
107. Collard HR, Saint S. Preventative practices for ventilator-associated pneumonia. En: Shojania KG, Duncan BW, McDonald KM, Wachter RM, editors. Making Health Care Safer: A critical analysis of patient safety practices. Evidence Report/Technology Assessment No 43. Agency for Healthcare Research and Quality publication 01-E058. Rockville, MD, Agency for Healthcare Research and Quality; 2001.